Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Para Influenza”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Early research (Phase 1)Study completedNCT00345670
What this trial is testing

Study to Evaluate the Safety of MEDI-534 Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3) in Healthy Children

Who this might be right for
Healthy
MedImmune LLC 120
Early research (Phase 1)Study completedNCT06604767
What this trial is testing

Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus InfectionMetapneumovirus InfectionParainfluenzae Virus Infection
Sanofi Pasteur, a Sanofi Company 390
Early research (Phase 1)Study completedNCT00366782
What this trial is testing

Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and Adults

Who this might be right for
Paramyxoviridae InfectionsVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 51
Not applicableUnknownNCT06392451
What this trial is testing

LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia

Who this might be right for
Influenza AInfluenza Type BCoronavirus Disease 2019+8 more
DiaSorin Molecular LLC 1,000
Not applicableStudy completedNCT00111878
What this trial is testing

Study to Evaluate MEDI-534 in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus InfectionsParainfluenza Infections
MedImmune LLC 120
Not applicableStudy completedNCT01302418
What this trial is testing

Collection and Testing of Respiratory Samples

Who this might be right for
QIAGEN ResPlex II Advanced PanelInfluenza ARespiratory Syncytial Virus Infections+15 more
QIAGEN Gaithersburg, Inc 272
Early research (Phase 1)Study completedNCT03392389
What this trial is testing

Safety, Reactogenicity, and Immunogenicity of mRNA-1653 in Healthy Adults

Who this might be right for
Human Metapneumovirus and Human Parainfluenza Infection
ModernaTX, Inc. 124
Testing effectiveness (Phase 2)Study completedNCT01924793
What this trial is testing

An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection

Who this might be right for
Parainfluenza
Ansun Biopharma, Inc. 23
Early research (Phase 1)Study completedNCT01139437
What this trial is testing

Safety of a Live Attenuated Human Parainfluenza Virus Type 2 (HPIV2) Vaccine for Adults, Children, and Infants

Who this might be right for
Human Parainfluenza Virus 2
National Institute of Allergy and Infectious Diseases (NIAID) 45
Testing effectiveness (Phase 2)Ended earlyNCT00508651
What this trial is testing

A Phase 1/2A Study to Evaluate the Safety, Immunogenicity, and Shedding of MEDI-560 in Infants 1 to < 12 Months of Age

Who this might be right for
Healthy
MedImmune LLC 30
Early research (Phase 1)Study completedNCT02564575
What this trial is testing

Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults

Who this might be right for
Hemorrhagic Fever, Ebola
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT04954287
What this trial is testing

Phase 1 Study of Intranasal PIV5 COVID-19 Vaccine Expressing SARS-CoV-2 Spike Protein in Healthy Adults and Adolescents

Who this might be right for
Covid19
CyanVac LLC 72
Early research (Phase 1)Study completedNCT00641017
What this trial is testing

Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus Vaccine

Who this might be right for
ParainfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 87
Testing effectiveness (Phase 2)Active Not RecruitingNCT06984094
What this trial is testing

Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults

Who this might be right for
RSV InfectionHuman Metapneumovirus InfectionParainfluenza Infection
Clover Biopharmaceuticals AUS Pty 612
Large-scale testing (Phase 3)Looking for participantsNCT03808922
What this trial is testing

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

Who this might be right for
Lower Respiratory Tract InfectionParainfluenzaImmunocompromised+1 more
Ansun Biopharma, Inc. 274
Testing effectiveness (Phase 2)Ended earlyNCT04933968
What this trial is testing

Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant

Who this might be right for
Respiratory Tract Viral InfectionsHuman Metapneumovirus (hMPV) InfectionParainfluenza (PIV) Infection+2 more
AlloVir 17
Not applicableActive Not RecruitingNCT05864118
What this trial is testing

Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses

Who this might be right for
Respiratory Tract Infections
University of Nebraska 1,000
Testing effectiveness (Phase 2)WithdrawnNCT01441024
What this trial is testing

DAS181 in Patients With Parainfluenza

Who this might be right for
Parainfluenza Infection
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT00493285
What this trial is testing

Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age

Who this might be right for
Respiratory Viral InfectionsRespiratory Syncytial Virus InfectionsParainfluenza Virus 3, Human
MedImmune LLC 49
Early research (Phase 1)Study completedNCT06026514
What this trial is testing

Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in Adults

Who this might be right for
SARS-CoV-2 Infection
National Institute of Allergy and Infectious Diseases (NIAID) 27
Load More Results